Ausdal Financial Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-6,479
Closed -$291K – 469
2022
Q4
$291K Sell
6,479
-140
-2% -$6.34K 0.04% 345
2022
Q3
$317K Hold
6,619
– – 0.05% 319
2022
Q2
$392K Buy
6,619
+500
+8% +$41K 0.06% 300
2022
Q1
$712K Buy
6,119
+610
+11% +$71.2K 0.1% 219
2021
Q4
$829K Sell
5,509
-2,001
-27% -$270K 0.11% 205
2021
Q3
$897K Sell
7,510
-1,000
-12% -$110K 0.13% 191
2021
Q2
$829K Buy
8,510
+774
+10% +$69K 0.13% 193
2021
Q1
$683K Sell
7,736
-2,343
-23% -$218K 0.12% 204
2020
Q4
$513K Buy
10,079
+5,077
+101% +$523K 0.1% 218
2020
Q3
$568K Sell
5,002
-500
-9% -$52.5K 0.14% 171
2020
Q2
$544K Sell
5,502
-3,100
-36% -$247K 0.18% 132
2020
Q1
$626K Buy
8,602
+90
+1% +$6.31K 0.22% 118
2019
Q4
$655K Sell
8,512
-357
-4% -$22K 0.19% 134
2019
Q3
$523K Buy
8,869
+357
+4% +$22.8K 0.19% 144
2019
Q2
$548K Buy
8,512
+1,562
+22% +$101K 0.21% 130
2019
Q1
$441K Sell
6,950
-3,075
-31% -$162K 0.18% 148
2018
Q4
$381K Sell
10,025
-7,750
-44% -$274K 0.19% 137
2018
Q3
$761K Sell
17,775
-4,725
-21% -$165K 0.21% 137
2018
Q2
$495K Sell
22,500
-12,150
-35% -$149K 0.15% 195
2018
Q1
$172K Buy
34,650
+5,000
+17% +$16.1K 0.06% 336
2017
Q4
$70K Buy
+29,650
New +$93.1K 0.03% 347

Other funds holding TNDM

Ausdal Financial Partners's TNDM Position: Q1 2023 in Review

Ausdal Financial Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 6,479 shares — an estimated $291K sold.

Ausdal Financial Partners first reported a position in TNDM in Q4 2017 and held it in 21 quarters. The position peaked at $897K in Q3 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Ausdal Financial Partners reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Ausdal Financial Partners sold 6,479 Tandem Diabetes Care shares in Q1 2023, an estimated $291K.
  • Ausdal Financial Partners first reported a position in Tandem Diabetes Care in Q4 2017 and held it in 21 quarters.
  • Ausdal Financial Partners's Tandem Diabetes Care position peaked at $897K in Q3 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Ausdal Financial Partners's 13F filing for Q1 2023, filed 4 May 2023.